Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F9P2M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,651
Award facts
- Contract value 100% obligated
- $18,651.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,651.46 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with an extensive portfolio of federal contract awards predominantly supporting the Defense Logistics Agency's Medical Supply Chain. Repatha (evolocumab) is a PCSK9 inhibitor used for cholesterol management in patients at high cardiovascular risk. As a major pharmaceutical distributor registered in SAM.gov, AmerisourceBergen fulfills federal procurement requirements through open competition, delivering medications across multiple therapeutic domains including cardiology, diabetes, neurology, and pain management, along with specialized medical supplies and auto-injectors to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9P2M?
SPE2DR26F9P2M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9P2M worth?
The government has obligated $18,651 on SPE2DR26F9P2M.
Is contract SPE2DR26F9P2M an order under another contract?
Yes. SPE2DR26F9P2M is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P2M competed?
The extent of competition for SPE2DR26F9P2M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award